Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 302

1.

The State of Breast Cancer Screening Guidelines: A Question and Answer Summary.

Kopans DB, Biggs KW, Pyatt RS Jr, Smetherman D, Friedberg EB.

J Am Coll Radiol. 2020 Feb 26. pii: S1546-1440(19)31439-5. doi: 10.1016/j.jacr.2019.11.030. [Epub ahead of print] No abstract available.

PMID:
32113863
2.

Deep Learning or Fundamental Descriptors?

Kopans DB.

Radiology. 2018 May;287(2):728-729. doi: 10.1148/radiol.2017173053. No abstract available.

PMID:
29668415
3.

Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.

Kopans DB.

Clin Imaging. 2018 Mar - Apr;48:vii-xi. doi: 10.1016/j.clinimag.2017.12.016.

PMID:
29549915
4.

False Information About Breast Cancer Screening.

Kopans DB.

JAMA Intern Med. 2018 Feb 1;178(2):298. doi: 10.1001/jamainternmed.2017.7081. No abstract available.

PMID:
29404607
5.

Breast cancer screening: Where have we been and where are we going? A personal perspective based on history, data and experience.

Kopans DB.

Clin Imaging. 2018 Jul-Aug;50:91-95. doi: 10.1016/j.clinimag.2017.12.013. Epub 2017 Dec 27. Review.

PMID:
29331672
6.

The Breast Cancer Screening "Arcade" and the "Whack-A-Mole" Efforts to Reduce Access to Screening.

Kopans DB.

Semin Ultrasound CT MR. 2018 Feb;39(1):2-15. doi: 10.1053/j.sult.2017.06.002. Epub 2017 Jun 28. Review.

PMID:
29317036
7.

Rebuttal comments.

Kopans DB.

Breast Cancer Res Treat. 2017 Nov;166(2):655-656. doi: 10.1007/s10549-017-4471-6. Epub 2017 Sep 16. No abstract available.

PMID:
28918479
8.

Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA.

J Am Coll Radiol. 2017 Sep;14(9):1137-1143. doi: 10.1016/j.jacr.2017.06.001. Epub 2017 Jun 22.

PMID:
28648873
9.

The Canadian National Breast Screening Studies are compromised and their results are unreliable. They should not factor into decisions about breast cancer screening.

Kopans DB.

Breast Cancer Res Treat. 2017 Aug;165(1):9-15. doi: 10.1007/s10549-017-4302-9. Epub 2017 May 20. Review.

PMID:
28528449
10.

Multimodal breast cancer imaging using coregistered dynamic diffuse optical tomography and digital breast tomosynthesis.

Zimmermann BB, Deng B, Singh B, Martino M, Selb J, Fang Q, Sajjadi AY, Cormier J, Moore RH, Kopans DB, Boas DA, Saksena MA, Carp SA.

J Biomed Opt. 2017 Apr 1;22(4):46008. doi: 10.1117/1.JBO.22.4.046008.

11.

More misinformation on breast cancer screening.

Kopans DB.

Gland Surg. 2017 Feb;6(1):125-129. doi: 10.21037/gs.2016.12.15.

12.

Breast-Cancer Tumor Size and Screening Effectiveness.

Kopans DB.

N Engl J Med. 2017 Jan 5;376(1):93-4. No abstract available.

PMID:
28060475
13.

Point: The New England Journal of Medicine Article Suggesting Overdiagnosis From Mammography Screening Is Scientifically Incorrect and Should Be Withdrawn.

Kopans DB.

J Am Coll Radiol. 2016 Nov;13(11S):R50-R52. doi: 10.1016/j.jacr.2016.09.026. No abstract available.

PMID:
27814814
14.

Breast cancer screening panels continue to confuse the facts and inject their own biases.

Kopans DB.

Curr Oncol. 2015 Oct;22(5):e376-9. doi: 10.3747/co.22.2880. No abstract available.

15.

Digital Breast Tomosynthesis: State of the Art.

Vedantham S, Karellas A, Vijayaraghavan GR, Kopans DB.

Radiology. 2015 Dec;277(3):663-84. doi: 10.1148/radiol.2015141303.

16.

The Faulty Analysis of Breast Cancer Screening Data.

Kopans DB.

Acad Radiol. 2016 Jan;23(1):116-7. doi: 10.1016/j.acra.2015.08.035. Epub 2015 Dec 1. No abstract available.

PMID:
26598484
17.

"Off Label" Use of FDA-Approved Devices and Digital Breast Tomosynthesis.

Kopans DB.

AJR Am J Roentgenol. 2015 Nov;205(5):1149-51. doi: 10.2214/AJR.15.14632.

PMID:
26496566
18.

Characterizing breast lesions through robust multimodal data fusion using independent diffuse optical and x-ray breast imaging.

Deng B, Fradkin M, Rouet JM, Moore RH, Kopans DB, Boas DA, Lundqvist M, Fang Q.

J Biomed Opt. 2015 Aug;20(8):80502. doi: 10.1117/1.JBO.20.8.080502.

19.

The UK Age Trial: screening women in their forties.

Kopans DB.

Lancet Oncol. 2015 Sep;16(9):1012-1013. doi: 10.1016/S1470-2045(15)00057-1. Epub 2015 Jul 20. No abstract available. Erratum in: Lancet Oncol. 2015 Nov;16(15):e528.

PMID:
26206145
20.

An open letter to panels that are deciding guidelines for breast cancer screening.

Kopans DB.

Breast Cancer Res Treat. 2015 May;151(1):19-25. doi: 10.1007/s10549-015-3373-8. Epub 2015 Apr 14. Review.

PMID:
25868866
21.

Study "guesstimated" how many cancers would have occurred without mammography screening.

Kopans DB.

BMJ. 2014 Nov 25;349:g6824. doi: 10.1136/bmj.g6824. No abstract available.

PMID:
25424500
22.

Reply to "Tomosynthesis assisting in localization of breast lesions for ultrasound targeting seen on one mammographic view only".

Kopans DB.

AJR Am J Roentgenol. 2014 Nov;203(5):W556. doi: 10.2214/AJR.14.12957. No abstract available.

PMID:
25341176
23.

The 20-year effort to reduce access to mammography screening: historical facts dispute a commentary in Cancer.

Kopans DB, Webb ML, Cady B.

Cancer. 2014 Sep 15;120(18):2792-9. doi: 10.1002/cncr.28791. Epub 2014 Jun 12.

24.

A new era in mammography screening.

Kopans DB.

Radiology. 2014 Jun;271(3):629-31. doi: 10.1148/radiol.14140177. No abstract available.

PMID:
24848957
25.

Arguments against mammography screening continue to be based on faulty science.

Kopans DB.

Oncologist. 2014 Feb;19(2):107-12. doi: 10.1634/theoncologist.2013-0184. No abstract available.

26.

Digital breast tomosynthesis from concept to clinical care.

Kopans DB.

AJR Am J Roentgenol. 2014 Feb;202(2):299-308. doi: 10.2214/AJR.13.11520. Review.

PMID:
24450669
27.

Reply to A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.

Webb ML, Kopans DB, Cady B.

Cancer. 2014 Sep 15;120(18):2937-8. doi: 10.1002/cncr.28525. Epub 2013 Dec 18. No abstract available.

28.

A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.

Webb ML, Cady B, Michaelson JS, Bush DM, Calvillo KZ, Kopans DB, Smith BL.

Cancer. 2014 Sep 15;120(18):2839-46. doi: 10.1002/cncr.28199. Epub 2013 Sep 9.

29.

Development of wire localization for occult breast lesions: Boston remembrances.

Hall FM, Kopans DB, Sadowsky NL, Homer MJ.

Radiology. 2013 Sep;268(3):622-7. doi: 10.1148/radiol.13121943. Review.

PMID:
23970507
30.

Digital breast tomosynthesis: a better mammogram.

Kopans DB.

Radiology. 2013 Jun;267(3):968-9. doi: 10.1148/radiol.13130086. No abstract available.

PMID:
23704296
31.

Point: The New England Journal of Medicine article suggesting overdiagnosis from mammography screening is scientifically incorrect and should be withdrawn.

Kopans DB.

J Am Coll Radiol. 2013 May;10(5):317-9; discussion 323. doi: 10.1016/j.jacr.2013.01.024. Epub 2013 Mar 28. No abstract available.

PMID:
23542028
32.

Do not jump too quickly to conclusions.

Kopans DB.

Breast Cancer Res. 2012 Jul 23;14(4):108. doi: 10.1186/bcr3213.

33.

Not so fast: the use of incomplete data to devalue the role of mammography screening.

Kopans DB.

Breast Cancer Res Treat. 2012 May;133(1):399. doi: 10.1007/s10549-012-1966-z. Epub 2012 Feb 14. No abstract available.

PMID:
22331480
34.

Just the facts: mammography saves lives with little if any radiation risk to the mature breast.

Kopans DB.

Health Phys. 2011 Nov;101(5):578-82. doi: 10.1097/HP.0b013e3182254e93.

PMID:
21979544
35.

Mammographic screening and "overdiagnosis".

Kopans DB, Smith RA, Duffy SW.

Radiology. 2011 Sep;260(3):616-20. doi: 10.1148/radiol.11110716. No abstract available.

PMID:
21846757
36.

Compositional-prior-guided image reconstruction algorithm for multi-modality imaging.

Fang Q, Moore RH, Kopans DB, Boas DA.

Biomed Opt Express. 2010 Jul 16;1(1):223-235.

37.

Screening for breast cancer among women in their 40s.

Kopans DB.

Lancet Oncol. 2010 Dec;11(12):1108-9. doi: 10.1016/S1470-2045(10)70272-2. No abstract available.

PMID:
21126682
38.

Combined optical and X-ray tomosynthesis breast imaging.

Fang Q, Selb J, Carp SA, Boverman G, Miller EL, Brooks DH, Moore RH, Kopans DB, Boas DA.

Radiology. 2011 Jan;258(1):89-97. doi: 10.1148/radiol.10082176. Epub 2010 Nov 9.

39.

The 2009 US Preventive Services Task Force (USPSTF) guidelines are not supported by science: the scientific support for mammography screening.

Kopans DB.

Radiol Clin North Am. 2010 Sep;48(5):843-57. doi: 10.1016/j.rcl.2010.06.005. Review.

PMID:
20868889
40.

The U.S. Preventive Services Task Force guidelines are not supported by the scientific evidence.

Kopans DB.

Radiology. 2010 Oct;257(1):294-5; author reply 295. doi: 10.1148/radiol.100920. No abstract available.

PMID:
20851947
41.

Characterization of masses in digital breast tomosynthesis: comparison of machine learning in projection views and reconstructed slices.

Chan HP, Wu YT, Sahiner B, Wei J, Helvie MA, Zhang Y, Moore RH, Kopans DB, Hadjiiski L, Way T.

Med Phys. 2010 Jul;37(7):3576-86.

42.

Re: "Quality of life and diagnostic imaging outcomes".

Kopans DB.

J Am Coll Radiol. 2010 Jul;7(7):546; author reply 546-7. doi: 10.1016/j.jacr.2010.05.003. No abstract available.

PMID:
20630398
43.

Re: "Saving lives: mammograms, breast cancer, and health insurance reform".

Kopans DB.

J Am Coll Radiol. 2010 Jul;7(7):545; author reply 545-6. doi: 10.1016/j.jacr.2010.05.001. No abstract available.

PMID:
20630396
44.

The 2009 U.S. Preventive Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn.

Kopans DB.

Radiology. 2010 Jul;256(1):15-20. doi: 10.1148/radiol.10100057. No abstract available.

PMID:
20574081
45.

The recent US preventive services task force guidelines are not supported by the scientific evidence and should be rescinded.

Kopans DB.

J Am Coll Radiol. 2010 Apr;7(4):260-4. doi: 10.1016/j.jacr.2009.12.008.

PMID:
20362940
46.

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.

Lee JM, McMahon PM, Kong CY, Kopans DB, Ryan PD, Ozanne EM, Halpern EF, Gazelle GS.

Radiology. 2010 Mar;254(3):793-800. doi: 10.1148/radiol.09091086.

47.

Enhanced imaging of microcalcifications in digital breast tomosynthesis through improved image-reconstruction algorithms.

Sidky EY, Pan X, Reiser IS, Nishikawa RM, Moore RH, Kopans DB.

Med Phys. 2009 Nov;36(11):4920-32.

48.

Mammography: yet another challenge.

Kopans DB.

Radiology. 2009 Dec;253(3):587-9. doi: 10.1148/radiol.2533091517. No abstract available.

PMID:
19952020
49.

Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

Schwartz GF, Hughes KS, Lynch HT, Fabian CJ, Fentiman IS, Robson ME, Domchek SM, Hartmann LC, Holland R, Winchester DJ; Consensus Conference Committee, Anderson BO, Arun BK, Bartelink H, Bernard P, Bonanni B, Cady B, Clough KB, Feig SA, Heywang-Köbrunner SH, Howell A, Isaacs C, Kopans DB, Mansel RE, Masood S, Palazzo JP, Pressman PI, Solin LJ, Untch M.

Breast J. 2009 Jan-Feb;15(1):4-16. doi: 10.1111/j.1524-4741.2008.00665.x.

50.

Combined optical imaging and mammography of the healthy breast: optical contrast derived from breast structure and compression.

Fang Q, Carp SA, Selb J, Boverman G, Zhang Q, Kopans DB, Moore RH, Miller EL, Brooks DH, Boas DA.

IEEE Trans Med Imaging. 2009 Jan;28(1):30-42. doi: 10.1109/TMI.2008.925082.

Supplemental Content

Loading ...
Support Center